174 related articles for article (PubMed ID: 15686719)
1. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
[TBL] [Abstract][Full Text] [Related]
2. Impact of rituximab therapy for treatment of acute humoral rejection.
Kaposztas Z; Podder H; Mauiyyedi S; Illoh O; Kerman R; Reyes M; Pollard V; Kahan BD
Clin Transplant; 2009; 23(1):63-73. PubMed ID: 19200217
[TBL] [Abstract][Full Text] [Related]
3. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
[TBL] [Abstract][Full Text] [Related]
4. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab.
Keren A; Hayes HM; O'Driscoll G
Transplant Proc; 2006 Jun; 38(5):1520-2. PubMed ID: 16797348
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression induction with daclizumab and antithymocyte globulin in cardiac transplantation: clinical experience with 8 cases.
Huang XS; Chen DZ; Chen LW; Li ZQ; Liao CX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):126-8. PubMed ID: 14965807
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of acute humoral rejection in a heart transplant patient.
Malafa M; Mancini MC; Myles JL; Gohara A; Dickinson JM; Walsh TE
J Heart Lung Transplant; 1992; 11(3 Pt 1):486-91. PubMed ID: 1610857
[TBL] [Abstract][Full Text] [Related]
8. Late allograft failure after heart transplantation: 2 unusual cases.
Boilson BA; Miller DV; Pereira NL
J Heart Lung Transplant; 2008 Sep; 27(9):1050-4. PubMed ID: 18765202
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
10. Intramyocardial electrogram recordings (IMEG) for diagnosis of cellular and humoral mediated cardiac allograft rejection.
Knosalla C; Grauhan O; Muller J; Pfitzmann R; Fietze E; Cohnert T; Volk HD; Hetzer R
Ann Thorac Cardiovasc Surg; 2000 Apr; 6(2):89-94. PubMed ID: 10870001
[TBL] [Abstract][Full Text] [Related]
11. Serial monitoring of humoral antibody-mediated rejection of cardiac allografts by C4d staining of interstitial capillaries.
Suggs J; Goodin J; Cruse JM; Lewis RE; Allen B; Bigler S; Moore C; Thompson R; McIntire H
Exp Mol Pathol; 2009 Feb; 86(1):41-5. PubMed ID: 19111538
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
13. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
[TBL] [Abstract][Full Text] [Related]
14. [Humoral rejection in heart transplantation. Report of 2 cases].
Castro P; Arriagada G; Moreno M; Morán S; Becker P; Zalaquett R; Godoy I; Córdova S
Rev Med Chil; 2000 Nov; 128(11):1245-9. PubMed ID: 11347512
[TBL] [Abstract][Full Text] [Related]
15. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of cardiogenic shock caused by humoral cardiac allograft rejection.
Saito S; Matsumiya G; Fukushima N; Sakaguchi T; Fujita T; Ueno T; Miyagawa S; Yamauchi A; Sawa Y
Circ J; 2009 May; 73(5):970-3. PubMed ID: 19088395
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vascular rejection with rituximab in cardiac transplantation.
Garrett HE; Duvall-Seaman D; Helsley B; Groshart K
J Heart Lung Transplant; 2005 Sep; 24(9):1337-42. PubMed ID: 16143254
[TBL] [Abstract][Full Text] [Related]
18. Successful reversal of acute cardiac allograft rejection with OKT*3 monoclonal antibody.
Costanzo-Nordin MR; Silver MA; O'Connell JB; Pifarre R; Grady KL; Winters GL; Murdock DK; Sullivan HJ; Grieco JG; Scanlon PJ
Circulation; 1987 Nov; 76(5 Pt 2):V71-80. PubMed ID: 3311459
[TBL] [Abstract][Full Text] [Related]
19. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
[TBL] [Abstract][Full Text] [Related]
20. [The pivotal role of the pathologist in transplantation].
Rotman S; Fontana M; Seydoux C; Venetz JP; Aubert JD; Pascual M
Rev Med Suisse; 2008 Feb; 4(145):480-3. PubMed ID: 18376526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
